Vijay Pande Leaves a16z to Start New Venture Capital Firm
After more than a decade of leading a16z’s biotech and healthcare investing practice, Vijay Pande made headlines this summer with his departure from the prestigious Silicon Valley venture-capital firm. Pande, a pioneer in the AI bio world, was an early advocate for computational biology, having founded the Folding@home initiative in 2000 and chaired Stanford’s biophysics program before transitioning to the world of venture capital.
In a recent interview on Post-Hoc Live, Pande shared his insights on the ever-evolving AI bio landscape and the opportunities and challenges of investing in it in 2025. You can watch the full interview on our YouTube livestream.
Exploring the Latest Trends in AI Bio
Pande delved into the current trends driving AI in bioinformatics and offered a preview of some of the topics that will be covered at Endpoints’ upcoming AI Day on October 14. (Be sure to sign up for free to access the livestream or on-demand recordings.)
Additionally, Pande discussed his post-a16z life, including his involvement in VZVC, a new VC firm that he recently co-founded with Zack Werner. This move brings Pande back into the world of investing, reaffirming his commitment to supporting innovative companies in the biotech and healthcare sectors.
With his wealth of experience and expertise, Pande’s new venture is poised to make a significant impact on the industry, driving forward advancements in AI and biotechnology.
Stay tuned for more updates on Pande’s latest ventures and the exciting developments in the AI bio space.
– Andrew Dunn
